DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine

Abstract

ABSTRACT The retrovirus HIV‐1 has been a major health issue since its discovery in the early 80s. In 2017, over 37 million people were infected with HIV‐1, of which 1.8 million were new infections that year. Currently, the most successful treatment regimen is the highly active antiretroviral therapy (HAART), which consists of a combination of three to four of the current 26 FDA‐approved HIV‐1 drugs. Half of these drugs target the reverse transcriptase (RT) enzyme that is essential for viral replication. One class of RT inhibitors is nucleoside reverse transcriptase inhibitors (NRTIs), a crucial component of the HAART. Once incorporated into DNA, NRTIs function as a chain terminator to stop viral DNA replication. Unfortunately, treatment with NRTIs is sometimes linked to toxicity caused by off‐target side effects. NRTIs may also target the replicative human mitochondrial DNA polymerase (Pol γ), causing long‐term severe drug toxicity. The goal of this work is to understand the discrimination mechanism of different NRTI analogues by RT. Crystal structures and kinetic experiments are essential for the rational design of new molecules that are able to bind selectively to RT and not Pol γ. Structural comparison of NRTI‐binding modes with both RT and Pol γ enzymes highlightsmore » key amino acids that are responsible for the difference in affinity of these drugs to their targets. Therefore, the long‐term goal of this research is to develop safer, next generation therapeutics that can overcome off‐target toxicity.« less

Authors:
ORCiD logo [1];  [1];  [2];  [3]; ORCiD logo [4]
  1. Department of Pharmacology Yale University School of Medicine New Haven Connecticut
  2. Laboratory of Biochemical Pharmacology, Department of Pediatrics, Center for AIDS Research Emory University School of Medicine Atlanta Georgia
  3. Department of Pharmacology and Toxicology University of Texas Medical Branch Galveston Texas, Sealy Center for Structural Biology University of Texas Medical Branch Galveston Texas
  4. Department of Pharmacology Yale University School of Medicine New Haven Connecticut, Department of Molecular Biophysics and Biochemistry Yale University School of Medicine New Haven Connecticut
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1547084
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Protein Science
Additional Journal Information:
Journal Name: Protein Science Journal Volume: 28 Journal Issue: 9; Journal ID: ISSN 0961-8368
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Bertoletti, Nicole, Chan, Albert H., Schinazi, Raymond F., Yin, Y. Whitney, and Anderson, Karen S.. Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine. United Kingdom: N. p., 2019. Web. doi:10.1002/pro.3681.
Bertoletti, Nicole, Chan, Albert H., Schinazi, Raymond F., Yin, Y. Whitney, & Anderson, Karen S.. Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine. United Kingdom. https://doi.org/10.1002/pro.3681
Bertoletti, Nicole, Chan, Albert H., Schinazi, Raymond F., Yin, Y. Whitney, and Anderson, Karen S.. Tue . "Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine". United Kingdom. https://doi.org/10.1002/pro.3681.
@article{osti_1547084,
title = {Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine},
author = {Bertoletti, Nicole and Chan, Albert H. and Schinazi, Raymond F. and Yin, Y. Whitney and Anderson, Karen S.},
abstractNote = {ABSTRACT The retrovirus HIV‐1 has been a major health issue since its discovery in the early 80s. In 2017, over 37 million people were infected with HIV‐1, of which 1.8 million were new infections that year. Currently, the most successful treatment regimen is the highly active antiretroviral therapy (HAART), which consists of a combination of three to four of the current 26 FDA‐approved HIV‐1 drugs. Half of these drugs target the reverse transcriptase (RT) enzyme that is essential for viral replication. One class of RT inhibitors is nucleoside reverse transcriptase inhibitors (NRTIs), a crucial component of the HAART. Once incorporated into DNA, NRTIs function as a chain terminator to stop viral DNA replication. Unfortunately, treatment with NRTIs is sometimes linked to toxicity caused by off‐target side effects. NRTIs may also target the replicative human mitochondrial DNA polymerase (Pol γ), causing long‐term severe drug toxicity. The goal of this work is to understand the discrimination mechanism of different NRTI analogues by RT. Crystal structures and kinetic experiments are essential for the rational design of new molecules that are able to bind selectively to RT and not Pol γ. Structural comparison of NRTI‐binding modes with both RT and Pol γ enzymes highlights key amino acids that are responsible for the difference in affinity of these drugs to their targets. Therefore, the long‐term goal of this research is to develop safer, next generation therapeutics that can overcome off‐target toxicity.},
doi = {10.1002/pro.3681},
journal = {Protein Science},
number = 9,
volume = 28,
place = {United Kingdom},
year = {2019},
month = {8}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1002/pro.3681

Citation Metrics:
Cited by: 14 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Insights into the Molecular Mechanism of Mitochondrial Toxicity by AIDS Drugs
journal, April 2001

  • Feng, Joy Y.; Johnson, Allison A.; Johnson, Kenneth A.
  • Journal of Biological Chemistry, Vol. 276, Issue 26
  • DOI: 10.1074/jbc.M101156200

Trapping HIV-1 Reverse Transcriptase Before and After Translocation on DNA
journal, January 2003

  • Sarafianos, Stefan G.; Clark, Arthur D.; Tuske, Steve
  • Journal of Biological Chemistry, Vol. 278, Issue 18
  • DOI: 10.1074/jbc.M212911200

Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ
journal, June 2015

  • Sohl, Christal D.; Szymanski, Michal R.; Mislak, Andrea C.
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 28
  • DOI: 10.1073/pnas.1421733112

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Structural basis for the binding and incorporation of nucleotide analogs with L-stereochemistry by human DNA polymerase  
journal, July 2014

  • Vyas, R.; Zahurancik, W. J.; Suo, Z.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 30
  • DOI: 10.1073/pnas.1401286111

Collaboration gets the most out of software
journal, September 2013


Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

Mechanism and fidelity of HIV reverse transcriptase.
journal, December 1992


Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP
journal, September 1999


Mechanistic Studies Comparing the Incorporation of (+) and (−) Isomers of 3TCTP by HIV-1 Reverse Transcriptase
journal, January 1999

  • Feng, Joy Y.; Anderson, Karen S.
  • Biochemistry, Vol. 38, Issue 1
  • DOI: 10.1021/bi982340r

Solvent content of protein crystals
journal, April 1968


Probing the Mechanistic Consequences of 5-Fluorine Substitution on Cytidine Nucleotide Analogue Incorporation by HIV-1 Reverse Transcriptase
journal, June 2003

  • Ray, Adrian S.; Schinazi, Raymond F.; Murakami, Eisuke
  • Antiviral Chemistry and Chemotherapy, Vol. 14, Issue 3
  • DOI: 10.1177/095632020301400301

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

PROCHECK: a program to check the stereochemical quality of protein structures
journal, April 1993

  • Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.
  • Journal of Applied Crystallography, Vol. 26, Issue 2
  • DOI: 10.1107/S0021889892009944

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
journal, November 1992

  • Schinazi, R. F.; McMillan, A.; Cannon, D.
  • Antimicrobial Agents and Chemotherapy, Vol. 36, Issue 11
  • DOI: 10.1128/AAC.36.11.2423

TLSMD web server for the generation of multi-group TLS models
journal, January 2006


The HIV therapy market
journal, June 2016

  • Gubernick, Steven I.; Félix, Nuno; Lee, Dolim
  • Nature Reviews Drug Discovery, Vol. 15, Issue 7
  • DOI: 10.1038/nrd.2016.69

Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase
journal, April 2010

  • Kellinger, Matthew W.; Johnson, Kenneth A.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 17
  • DOI: 10.1073/pnas.0913946107

Structural basis for the D-stereoselectivity of human DNA polymerase β
journal, April 2017

  • Vyas, Rajan; Reed, Andrew J.; Raper, Austin T.
  • Nucleic Acids Research, Vol. 45, Issue 10
  • DOI: 10.1093/nar/gkx252

The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro.
journal, January 1992

  • Coates, J. A.; Cammack, N.; Jenkinson, H. J.
  • Antimicrobial Agents and Chemotherapy, Vol. 36, Issue 1
  • DOI: 10.1128/AAC.36.1.202

Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective
journal, October 2003

  • Lewis, William; Day, Brian J.; Copeland, William C.
  • Nature Reviews Drug Discovery, Vol. 2, Issue 10
  • DOI: 10.1038/nrd1201

DNA Polymerase Fidelity:  Kinetics, Structure, and Checkpoints
journal, November 2004

  • Joyce, Catherine M.; Benkovic, Stephen J.
  • Biochemistry, Vol. 43, Issue 45
  • DOI: 10.1021/bi048422z

Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography
journal, August 2017

  • Chan, Albert H.; Lee, Won-Gil; Spasov, Krasimir A.
  • Proceedings of the National Academy of Sciences, Vol. 114, Issue 36
  • DOI: 10.1073/pnas.1711463114

Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicity
journal, January 2009

  • Maagaard, Anne; Kvale, Dag
  • Scandinavian Journal of Infectious Diseases, Vol. 41, Issue 11-12
  • DOI: 10.3109/00365540903186181

Optimal description of a protein structure in terms of multiple groups undergoing TLS motion
journal, March 2006

  • Painter, Jay; Merritt, Ethan A.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 4
  • DOI: 10.1107/S0907444906005270

Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
journal, February 2017

  • Kudalkar, Shalley N.; Beloor, Jagadish; Chan, Albert H.
  • Molecular Pharmacology, Vol. 91, Issue 4
  • DOI: 10.1124/mol.116.107755

Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design
journal, August 2008

  • Bauman, Joseph D.; Das, Kalyan; Ho, William C.
  • Nucleic Acids Research, Vol. 36, Issue 15
  • DOI: 10.1093/nar/gkn464

Visualizing the Molecular Interactions of a Nucleotide Analog, GS-9148, with HIV-1 Reverse Transcriptase–DNA Complex
journal, April 2010

  • Lansdon, Eric B.; Samuel, Dharmaraj; Lagpacan, Leanna
  • Journal of Molecular Biology, Vol. 397, Issue 4
  • DOI: 10.1016/j.jmb.2010.02.019

XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals
journal, September 2003

  • Kantardjieff, Katherine A.; Rupp, Bernhard
  • Protein Science, Vol. 12, Issue 9
  • DOI: 10.1110/ps.0350503

Structural Insights into the Post-Chemistry Steps of Nucleotide Incorporation Catalyzed by a DNA Polymerase
journal, December 2016

  • Reed, Andrew J.; Vyas, Rajan; Raper, Austin T.
  • Journal of the American Chemical Society, Vol. 139, Issue 1
  • DOI: 10.1021/jacs.6b11258

A mechanism for all polymerases
journal, January 1998

  • Steitz, Thomas A.
  • Nature, Vol. 391, Issue 6664
  • DOI: 10.1038/34542

Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)
journal, August 2016

  • Salie, Zhe Li; Kirby, Karen A.; Michailidis, Eleftherios
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 33
  • DOI: 10.1073/pnas.1605223113

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

Genetic risks of antiviral nucleoside analogues – a survey
journal, February 2001


Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA
journal, December 2002